Dil board to consider final dividend

16 May 2017 Evaluate

Dil has informed that the meeting(s) of the Audit Committee and Board of Directors of the Company are scheduled to be held on May 30, 2017, to consider and approve Audited financial statements (Standalone and Consolidated) of the Company for the quarter and year ended March 31, 2017 and recommend final equity dividend, if any, for the financial year 2016-17. Further, in compliance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and the Company’s Code of Conduct to Regulate, Monitor and Report Trading by Insiders, it is hereby notified that ‘Trading Window’ (period for trading in Company’s securities) shall remain closed from May 13, 2017 till the close of business hours on June 01, 2017, for approval of the Audited financial results (Standalone and Consolidated) of the Company, for the quarter and year ended March 31, 2017 along with audited financial results for the fourth quarter (which shall be balancing figure) and recommendation of final dividend, if any for the said financial year. During the closure of Trading Window, all Directors, Promoters, Insiders, Designated Persons including Auditors shall not, directly or indirectly trade or deal or enter into any transaction involving sale or purchase of the Company’s Equity Shares, either in their own name or in the name of their Immediate Relatives.

The above information is a part of company’s filings submitted to BSE.

Fermenta Biotech Share Price

289.65 -0.85 (-0.29%)
24-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.50
Dr. Reddys Lab 1201.45
Cipla 1551.30
Lupin 2104.90
Zydus Lifesciences 879.85
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...